Surmodics, Inc. (SRDX)
Market Cap | 268.81M |
Revenue (ttm) | 102.97M |
Net Income (ttm) | -35.96M |
Shares Out | 14.13M |
EPS (ttm) | -2.58 |
PE Ratio | n/a |
Forward PE | 81.97 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 80,921 |
Open | 18.53 |
Previous Close | 18.23 |
Day's Range | 18.36 - 19.03 |
52-Week Range | 16.00 - 39.99 |
Beta | 1.02 |
Analysts | Buy |
Price Target | 60.00 (+215.46%) |
Earnings Date | Jul 26, 2023 |
About SRDX
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to pr... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for SRDX stock is "Buy." The 12-month stock price forecast is $60.0, which is an increase of 215.46% from the latest price.
News

Top 5 Health Care Stocks That Could Blast Off In May - Coherus BioSciences (NASDAQ:CHRS), Intercept Pharma (NASDAQ:ICPT)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Surmodics to Participate in the Jefferies Healthcare Conference on June 8
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #JefferiesHealthcareConference--Surmodics today announced that management will present at the Jefferies Healthcare Conference on Thursday, June 8, at 1:30 p.m. E...

Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #ConferenceCall--Surmodics today reported financial results for its second quarter ended March 31, 2023, and updated its financial guidance for its fiscal year 2...

Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #MedicalDevice--The PROWL registry will collect real-world efficacy and safety outcomes data for endovascular interventions using the Pounce thrombectomy system.

Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #ConferenceCall--Surmodics announced that second quarter of fiscal year 2023 financial results will be released before the market opens on Wednesday, April 26.

Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #MedicalDevice--The new line of Surmodics' Sublime microcatheters rounds out a complete line of Sublime Radial Access Platform products.

Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #InVitroDiagnostic--Surmodics management will participate in investor meetings at the Needham Virtual Healthcare Conference and will present at 9:15 a.m. CT on A...

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
NEW YORK , March 31, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASD...

Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that it has ...

ROSEN, A LEADING LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
NEW YORK , March 17, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASD...

SRDX INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
NEW YORK , March 10, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NAS...

Surmodics to Participate in Upcoming Investor Conferences in March
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that managem...

NATIONALLY RANKED ROSEN LAW FIRM Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
NEW YORK , March 1, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDA...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surmodics, Inc. - SRDX
NEW YORK , Feb. 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surmodics, Inc. ("Surmodics" or the "Company") (NASDAQ: SRDX). Such investors are advised to co...

ROSEN, Global Investor Counsel, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
New York, New York--(Newsfile Corp. - February 17, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sur...

Surmodics Investigated by Block & Leviton for Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Boston, Massachusetts--(Newsfile Corp. - February 15, 2023) - Block & Leviton is investigating Surmodics, Inc. (NASDAQ: SRDX) for potential securities law violations. Investors who have lost money in ...

SRDX INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
NEW YORK , Feb. 8, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Surmodics Inc. (...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - February 6, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - February 3, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - January 31, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

Surmodics to Host Virtual Annual Meeting of Shareholders
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeti...

Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Boston, Massachusetts--(Newsfile Corp. - January 30, 2023) - Block & Leviton is investigating Surmodics, Inc. (NASDAQ: SRDX) for potential securities law violations. Investors who have lost money in t...

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - January 30, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

INVESTIGATION NOTICE: The Schall Law Firm Announces It is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surmodics, Inc...